ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Therapeutic Mycophenolic Acid Area-Under-Curve (MPA AUC) Levels Abolish Donor-Specific Antibody Formation in Established and De Novo Renal Transplant Patients

    M. Waybill, S. Narins, R. Scott, H. Yang

    PinnacleHealth Transplantation, Harrisburg, PA

    Background: Donor-specific antibody (DSA) formation is a key factor in development of antibody-mediated rejection and irreversible renal dysfunction. Prevention of DSA formation is critical, mandating…
  • 2013 American Transplant Congress

    Minimization of Immunosuppression for ABO-Incompatible Kidney Transplantation Based on the Strength of Pretreatment Anti A/B Antibody Titer

    S. Narumi, Y. Watarai, T. Yamamoto, M. Tsujita, T. Hiramitsu, K. Nanmoku, N. Goto, A. Katayama, T. Ueki, A. Takeda, K. Morozumi, K. Uchida, T. Kobayashi

    Transplant Surgery and Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Japan; Applied Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Acute antibody mediated rejection (AMR) used to be a major problem in ABO-incompatible KidneyTransplantation (ABOi-KTx), and currently rituximab has been accepted to reduce the prevalence…
  • 2013 American Transplant Congress

    Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients

    M. Kim, M. Pavlakis, C. Rogers

    Beth Israel Deaconess Medical Center, Boston, MA

    Sirolimus (SRL) based immunosuppression regimens are used in kidney transplant recipients (KTRs) to avoid tacrolimus (TAC) toxicity. KTRs have a high risk of cardiovascular events…
  • 2013 American Transplant Congress

    Identification of Common Blood-Based Biomarker Gene Panels for the Diagnosis of Renal and Cardiac Acute Allograft Rejection

    S. Roedder, L. Li, K. Kush, S. Hsieh, H. Luikart, A. Yang, H. Valentine, M. Sarwal

    Transplantation Research, BIOMARC Program, California Pacific Medical Center, Sutter Health, San Francisco, CA; Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA

    To validate a peripheral blood transcriptional biomarker panel diagnostic for acute renal allograft rejection for the diagnosis and prediction of acute cardiac allograft rejection we…
  • 2013 American Transplant Congress

    Effective Federal Advocacy: The Case for HIV-Infected Deceased Organ Donors

    B. Boyarsky, K. Gebo, P. Stock, D. Segev

    Johns Hopkins, Baltimore; UCSF, San Francisco

    Background. HIV is no longer a contraindication to solid organ transplantation. For HIV-infected patients, HIV-infected deceased donors (HIVDD) could attenuate the organ shortage and waitlist…
  • 2013 American Transplant Congress

    Incidence of BKV after Kidney Transplantation with Tacrolimus (FK) Based Immunosuppression and Alemtuzumab Induction: A Retrospective Analysis of Donation after-Cardiac Death (DCD) vs. Donation after Brain Death (DBD)

    H. Lam, S. Li, V. Gunabushanam, A. Tevar, H. Tan, A. Basu, M. Sturdevant, A. Humar, J. McCauley, C. Wu, N. Shah, P. Sood, P. Randhawa, A. Zeevis, J. Lunz, R. Shapiro

    Abdominal Transplant Surgery, UPMC, Pittsburgh; Transplant Nephrology, UPMC, Pittsburgh; Transplant Pathology, UPMC, Pittsburgh

    Introduction: With increasing organ shortage, transplant centers are increasing the utilization of DCD organs. However, the incidence of BKV has not been well investigated when…
  • 2013 American Transplant Congress

    Gradual vs Rapid Withdrawal of Immunosuppression after Kidney Allograft Failure Results in Less Allosensitization, Decreased Rate of De-Novo Donor Specific Antibody and Reduced Need for Allograft Nephrectomy

    S. Rao, R. Bray, S. Perez, S. Pastan, H. Gebel, A. Chami

    Transplant Nephrology, Emory University Hospital, Atlanta, GA; Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA; Deparment of Surgery, Emory University Hospital, Atlanta, GA

    Aim- Allosensitization after renal allograft failure is a major obstacle to re-transplantation.Withdrawal of immunosuppression after allograft failure is associated with sensitization. However, prolonged continuation of…
  • 2013 American Transplant Congress

    Comparable Risk of End-Stage Renal Disease (ESRD) in Liver Transplant Alone (LTA) and Simultaneous Liver Kidney (SLK) Recipients Who Had Pre-LT Kidney Biopsy for Renal Dysfunction or Proteinuria

    H. Wadei, M. Mai, M. Prendergast, A. Keaveny, S. Pungpapong, T. Gonwa

    Transplantation, Mayo Clinic, Jacksonville, FL

    Data concerning the utility of kidney biopsy in liver transplant (LT) candidates with renal dysfunction and/or proteinuria is lacking. Methods: 67 LT candidates with iothalamate…
  • 2013 American Transplant Congress

    Plasma Soluble IL-6 Receptor (SIL-6R) Levels Are Significantly Elevated during Antibody-Mediated Rejection (ABMR) in Highly-HLA Sensitized Renal Allograft Recipients (HS Pts)

    B. Shin, J. Watanabe, S. Ge, A. Vo, S. Jordan, M. Toyoda

    Medicine, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA

    Background: ABMR episodes involve multiple immunologic and inflammatory pathways. IL-6/IL-6R interactions have pleiotropic effects on immunity and inflammation and may have relevance to ABMR. Recent…
  • 2013 American Transplant Congress

    Pancreas Re-Transplantation Graft Survival Is Comparable to Primary Pancreas after Kidney Transplantation

    J. Seal, M. Selzner, M. Marquez, F. Bazerbachi, I. McGilvray, J. Schiff, A. Norgate, M. Cattral

    Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, ON, Canada; Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, ON, Canada

    Background: Reports on the outcomes of pancreas re-transplantation are scarce in the modern era. We compared the outcome of pancreas re-transplantation with primary pancreas after…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences